Insulin analogues: Searching for a physiological replacement Análoges de insulina: En búsqueda del reemplazo fisiológico
Artículo

Open/ Download
Publication date
2006Metadata
Show full item record
Cómo citar
Eyzaguirre C., Francisca
Cómo citar
Insulin analogues: Searching for a physiological replacement Análoges de insulina: En búsqueda del reemplazo fisiológico
Abstract
Insulin analogues, developed by molecular engineering, have structural changes in the A and B insulin chains. These modifications change their action profile, rendering insulin replacement closer to physiology. Rapid acting analogues like lispro, a spart and glulisine, are absorbed rapidly from the subcutaneous tissue to the circulation. In addition, two long acting insulin analogues have been developed: glargine and detemir. The combination of a long acting insulin, to maintain baseline levels, and multiple daily doses of a rapid acting analogue are the mainstay of basal-bolus therapy. Multiples studies have compared human insulin (NPH and regular) with insulin analogues in patients with type 1 or 2 diabetes mellitus, showing an improvement in the metabolic control, fewer hypoglycemic events and better quality of life. In summary, insulin analogues offer new therapeutic options and allow an individualized intensive treatment.
Indexation
Artículo de publicación SCOPUS
Quote Item
Revista Medica de Chile, Volumen 134, Issue 2, 2018, Pages 239-250
Collections
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile
Related items
Showing items related by title, author, creator and subject.
-
Bazaes Castillo, Rodrigo Antonio; Petry, C. J.; Ong, Ken; Avila, Alejandra; Dunger, D. B.; Mericq, Verónica (BLACKWELL PUBLISHING, 2003-11)AIMS We have previously demonstrated that insulin sensitivity and secretion at age 1 year was in part related to variation in weight and height gain during infancy. In order to determine whether genetic variation at the ...
-
Iñíguez Vila, Germán; Ong, Ken; Bazaes Castillo, Rodrigo Antonio; Avila, Alejandra; Salazar, Teresa; Dunger, David; Mericq, Verónica (2006-11)Introduction: Insulin resistance ( IR) develops as early as age 1 to 3 yr in small for gestational age ( SGA) infants who show rapid catch- up postnatal weight gain. In contrast, greater insulin secretion is related to ...
-
Galgani Fuentes, José; Ravussin, E. (Springer, 2012)Aims/hypothesis Insulin resistance is characterised by impaired glucose utilisation when measured by a euglycaemic– hyperinsulinaemic clamp. We hypothesised that, in response to postprandial conditions, non-diabetic ...